UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Final 5-Year Results of Z-FAST Trial: Adjuvant Zoledronic Acid Maintains Bone Mass in Postmenopausal Breast Cancer Patients Receiving Letrozole

Cancer, 2012-03, Vol.118 (5), p.1192-1201

2012

Volltextzugriff (PDF)

Zoledronic Acid Inhibits Adjuvant Letrozole–Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

Journal of clinical oncology, 2007-03, Vol.25 (7), p.829-836

2007

Volltextzugriff (PDF)

Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma

Journal of clinical oncology, 2014-09, Vol.32 (25), p.2765-2772

2014

Volltextzugriff (PDF)

Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX-Bevacizumab in Colorectal Cancer

Clinical colorectal cancer, 2012-06, Vol.11 (2), p.101-111

2012

Volltextzugriff (PDF)

Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical Trial

JAMA oncology, 2017-07, Vol.3 (7), p.906

2017

Volltextzugriff (PDF)

Final 5‐year results of Z‐FAST trial

Cancer, 2012-03, Vol.118 (5), p.1192-1201

2012

Volltextzugriff (PDF)

Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen‐independent prostate carcinoma

Cancer, 2004-02, Vol.100 (4), p.746-750

2004

Volltextzugriff (PDF)

Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II .beta. isoform

Biochemistry (Easton), 1991-10, Vol.30 (41), p.9953-9961

1991

Volltextzugriff (PDF)

Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group study

Journal of clinical oncology, 1993-01, Vol.11 (1), p.161-165

1993

Volltextzugriff (PDF)

Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in patients with metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.4504-4504

2013

Volltextzugriff (PDF)

Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin

Cancer research (Chicago, Ill.), 1995-03, Vol.55 (6), p.1339-1346

1995

Volltextzugriff (PDF)

Dissociation of Antitumor Potency from Anthracycline Cardiotoxicity in a Doxorubicin Analog

Science (American Association for the Advancement of Science), 1985-06, Vol.228 (4707), p.1544-1546

1985

Volltextzugriff (PDF)

Methylazoxyprocarbazine, the active metabolite responsible for the anticancer activity of procarbazine against L1210 leukemia

Cancer research (Chicago, Ill.), 1989-05, Vol.49 (9), p.2442-2447

1989

Volltextzugriff (PDF)

Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase IIα messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone

Cancer research (Chicago, Ill.), 1995-11, Vol.55 (21), p.4962-4971

1995

Volltextzugriff (PDF)

Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA

Cancer research (Chicago, Ill.), 1985-09, Vol.45 (9), p.4091-4096

1985

Volltextzugriff (PDF)

Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas

Modern pathology, 1997-03, Vol.10 (3), p.168

1997

Volltextzugriff (PDF)

Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression

Cancer research (Chicago, Ill.), 1989-08, Vol.49 (16), p.4542-4549

1989

Volltextzugriff (PDF)

Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen

Journal of clinical oncology, 1995-08, Vol.13 (8), p.2117-2122

1995

Volltextzugriff (PDF)

Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin

Oncology research, 1995, Vol.7 (2), p.83

1995

Volltextzugriff (PDF)

Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe

Annals of internal medicine, 1984-10, Vol.101 (4), p.440

1984

Volltextzugriff (PDF)

Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission

Cancer research (Chicago, Ill.), 1986-05, Vol.46 (5), p.2369-2373

1986

Volltextzugriff (PDF)

Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis

Cancer research (Chicago, Ill.), 1990-09, Vol.50 (18), p.5931-5936

1990

Volltextzugriff (PDF)

Development and characterization of a human sarcoma cell line, MES-SA, sensitive to multiple drugs

Cancer research (Chicago, Ill.), 1983-10, Vol.43 (10), p.4943-4950

1983

Volltextzugriff (PDF)

Peripherally Inserted Venous Catheters: Low-Risk Alternatives for Ongoing Venous Access

Survey of anesthesiology, 1994-08, Vol.38 (4), p.211

1994

Volltextzugriff (PDF)

Non-enzymatic activation of procarbazine to active cytotoxic species

Oncology research, 1992, Vol.4 (2), p.49

1992

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Humans
(25)
Science & Technology
(22)
Life Sciences & Biomedicine
(21)
Oncology
(18)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Female
(14)
Pharmacology. Drug Treatments
(14)
Antineoplastic Agents
(13)
Middle Aged
(13)
Adult
(10)
Aged
(10)
General Aspects
(10)
Male
(9)
Drug Resistance
(7)
Aged, 80 And Over
(6)
Cell Line
(6)
Animals
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(8)
Journal Of Clinical Oncology
(6)
Cancer
(4)
Oncology Research
(2)
Annals Of Internal Medicine
(1)
Biochemistry
(1)
Cancer Chemotherapy And Pharmacology
(1)
Clinical Colorectal Cancer
(1)
Jama Oncology
(1)
Modern Pathology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Final 5-Year Results of Z-FAST Trial: Adjuvant Zoledronic Acid Maintains Bone Mass in Postmenopausal Breast Cancer Patients Receiving Letrozole

Zoledronic Acid Inhibits Adjuvant Letrozole–Induced Bone Loss in Postmenopausal Women With Early Breast Cancer

Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma

Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX-Bevacizumab in Colorectal Cancer

Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical Trial

Final 5‐year results of Z‐FAST trial

Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen‐independent prostate carcinoma

Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II .beta. isoform

Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group study

Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in patients with metastatic renal cell carcinoma (mRCC)

Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin

Dissociation of Antitumor Potency from Anthracycline Cardiotoxicity in a Doxorubicin Analog

Methylazoxyprocarbazine, the active metabolite responsible for the anticancer activity of procarbazine against L1210 leukemia

Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase IIα messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone

Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA

Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas

Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression

Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen

Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin

Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe

Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission

Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis

Development and characterization of a human sarcoma cell line, MES-SA, sensitive to multiple drugs

Peripherally Inserted Venous Catheters: Low-Risk Alternatives for Ongoing Venous Access

Non-enzymatic activation of procarbazine to active cytotoxic species

Suchergebnisse filtern